DIAGNOSEVERFAHREN FÜR KREBS, DAS DURCH DEN NACHWEIS DER DELETION DES G-CSF-EXONS 3 GEKENNZEICHNET IST

摘要

Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.